Clinical Trial: Short-Term CBD Dosing Not Associated With Liver Abnormalities
January 22, 2026
January 22, 2026
WASHINGTON, Jan. 22 [Category: Sociological] -- The National Organization for the Reform of Marijuana Laws posted the following news release:
* * *
Clinical Trial: Short-Term CBD Dosing Not Associated With Liver Abnormalities
*
Brisbane, Australia: The use of CBD-dominant medical cannabis products by cancer patients is not associated with liver damage, including the elevated production of the alanine aminotransferase (ALT) enzyme, according to . . .
* * *
Clinical Trial: Short-Term CBD Dosing Not Associated With Liver Abnormalities
*
Brisbane, Australia: The use of CBD-dominant medical cannabis products by cancer patients is not associated with liver damage, including the elevated production of the alanine aminotransferase (ALT) enzyme, according to . . .